Exporter

Codes ATC: J01DB01
EMLc
Indication
Acute pharyngitis Code ICD11: CA02
INN
Cefalexin
Type de médicament
Chemical agent
Groupes d'antibiotiques
Type de liste
Liste de base (EML)
(EMLc)
Formulations
Oral > Liquid: 125 mg per 5 mL (anhydrous) powder for oral liquid ; 250 mg per 5 mL (anhydrous) powder for oral liquid
Oral > Solid: 250 mg (as monohydrate) ; 500 mg (as monohydrate) (EML)
Oral > Solid > dispersible tablet: 125 mg (EMLc) ; 250 mg (EMLc)
Historique des statuts LME
Ajouté pour la première fois en 2017 (TRS 1006)
Modifié en 2021 (TRS 1035)
Modifié en 2023 (TRS 1049)
Sexe
Tous
Âge
Aussi recommandé pour les enfants
Équivalence thérapeutique
La recommandation concerne ce médicament spécifique
Renseignements sur le brevet
Patents have expired in most jurisdictions
Lire la suite sur les brevets.
Recommandation du comité d'experts
Following the review of the age-appropriateness of formulations on the EMLc, the Expert Committee recommended: - the addition of new formulations of amoxicillin (dispersible, scored tablet, 250 mg and 500 mg) to the EMLc. - the addition of new formulations of cefalexin (dispersible tablet 125 mg and 250 mg) to the EMLc. - the addition of a new strength formulation of clarithromycin (solid oral dosage form 250 mg) to the EMLc. - the deletion of clarithromycin 500 mg solid oral dosage form from the EMLc.
Recommandations de la LME : Acute pharyngitis
Premier choix
Second choix
Watchful waiting, symptom relief and no antibiotic treatment should be considered as the first-line treatment option.
Premier choix
Second choix